Among healthy adults receiving the JN.1- or KP.2-adapted mRNA seasonal COVID-19 vaccine, neutralizing antibody responses were similar.
Considerable cancer disparities persist in the US, according to a recent report published by the American Association for Cancer Research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results